Infectious Disease

When historical data dominates, controversy is sure to exist. Such is the case for the use of antibiotics in patients with group A streptococcal pharyngitis.

Jeffrey Goad, PharmD, MPH, FAPhA, discusses vaccine recommendations for immunocompromised patients.

Carbapenems are often considered to have the broadest spectrum of activity among all antibiotic classes.

Solithromycin, the first drug in the fluoroketolide class of macrolide antibiotics, recently demonstrated noninferiority to moxifloxacin in the treatment of community-acquired bacterial pneumonia.

Those preparing to travel for spring break may approach student pharmacists with questions about the Zika virus.

Invasive fungal disease due to the genus Candida can be life threatening.

Pneumococcal immunization recommendations have changed multiple times in previous years, but the rationale behind the new recommendations may not be clearly understood.

Whether it is complacency, inconvenience, or lack of confidence, some patients just need an extra push to get their annual flu shot.

With flu season well under way, many pharmacy technicians have found themselves directing a myriad of flu-related questions to pharmacists.

The Joint Commission's proposed standard on antimicrobial stewardship means higher demand for infectious diseases pharmacists and physicians, but will there be enough specialists to satisfy it?

Skipping a flu shot may put patients at greater risk for flu-related pneumonia.

The Advisory Committee on Immunization Practices recently updated the recommended interval between the 13-valeant pneumococcal conjugate vaccine and the 23-valeant pneumococcal polysaccharide vaccine in low-risk elderly patients.

More evidence is needed to figure out how to dose vancomycin in obese patients, but a new protocol could play a role.

Elias Cachine, PharmD, BCPS (AQ-10) explains what steps pharmacists should take when treating infections in geriatric patients.

Research may improve the diagnosis of infectious and autoimmune diseases, including rheumatoid arthritis and HIV.

Allergan's ceftaroline fosamil is now approved for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia with a shorter infusion time.

Data tracking may someday become a key component in limiting disease spread.

The FDA has fast-tracked Cempra's solithromycin to treat community acquired bacterial pneumonia.

Infectious diseases pharmacotherapy is a challenging subject.

The dispensing model for pyrimethamine has changed, which may cause delays in therapy.

Here are new drugs for 2015 that pharmacists can expect to handle.

Pharmacists can play an important role in counseling patients on the common symptoms of MERS.

Here are new drugs for 2015 pharmacists can expect to handle.

The FDA has cleared Roche's cobas Strep A test for use by health care professionals in non-traditional settings, including pharmacies and physician offices.

What should these pharmacists do?

Hospitals can now order Actavis's ceftazidime-avibactam (Avycaz) to treat serious infections in adults.

Record number of orphan drugs approved in 2014.

Gilead Sciences is seeking FDA approval for emtricitabine/tenofovir alafenamide.

Patients who suffer from chronic conditions are at a higher risk for medical-related episodes and errors.

The FDA has granted 2 breakthrough therapy designations to grazoprevir/elbasvir.